Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 631 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07122986RecruitingPhase 1
Testing a new E. coli vaccine in healthy adults
This study tests an experimental vaccine designed to protect against E. coli bacteria. It is for healthy adults aged 18 to 63 who want to help researchers see if the vaccine is safe and produces an immune response.
Anaheim, CaliforniaAges 18–64 - NCT07123467RecruitingPhase 3
Study on CBD and learning for generalized anxiety
This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.
Detroit, MichiganAges 18–45 - NCT07123909Recruiting
Immune adsorbent therapy for dialysis patients with inflammation
This study tests a therapy that absorbs inflammatory substances from the blood during dialysis. It may help people on dialysis who have ongoing inflammation, shown by high IL-6 or CRP levels.
MoscowAges 18 years+ - NCT07126106Recruiting
Testing a computer program to find sepsis earlier in the ICU
This study tests a new computer program that helps doctors find serious infections (sepsis and bacteremia) earlier in ICU patients. If you join, the program will analyze your health data to see if it can better predict these infections, which could help you get faster treatment.
Seyrantepe, IstanbulAges 18 years+ - NCT07133828RecruitingPhase 1
Safety study of BIIB142 in healthy adults
This trial tests the safety of a new drug called BIIB142 and how the body processes it. It is for healthy volunteers aged 18 to 55.
Las Vegas, NevadaAges 18–55 - NCT07140094Recruiting
Long COVID Relief Through Learning Mindfulness
This study tests whether a mindfulness program can help ease long COVID symptoms. You will learn simple mindfulness techniques and see if they improve your daily life.
New York, New YorkAges 18 years+ - NCT07146737Recruiting
Predicting cornea shape after ICL implant surgery
This trial uses a computer model to predict how the cornea changes after ICL implantation, which is a lens placed inside the eye to correct vision. It tests if the model can help doctors plan safer surgeries.
Nanchang, JiangxiAges 18–45 - NCT07147634Recruiting
Outdoor science classes and child well-being study
This study tests whether outdoor science lessons improve well-being, learning, and connection to nature in 5th and 6th graders. It also looks at how outdoor time might help with eco-anxiety and stress.
Montreal, QuebecAges Any age - NCT07152119Recruiting
Study of Litfulo for severe alopecia areata in routine care
This study looks at how well Litfulo capsules work for people with severe alopecia areata in everyday medical practice. It is for adults and teens aged 12 or older who are starting Litfulo as part of their normal care.
SeoulAges 12 years+ - NCT07153159RecruitingPhase 1
How etrasimod enters breast milk in healthy breastfeeding women
This study looks at how the medication etrasimod gets into breast milk after a single dose. If you are a healthy breastfeeding woman at least 12 weeks after giving birth, you may be able to help researchers understand this process. You would need to stop breastfeeding temporarily for 21 days.
Brussels, Bruxelles-capitale, Région deAges 18–55 - NCT07157566Recruiting
Mindfulness and digital health for PE students
This trial compares mindfulness, digital health tools, or a mix of both to see how they affect learning and daily health habits. If you are a PE student aged 18–25 who speaks Chinese and is generally healthy, you may be able to join.
MacaoAges 18–25 - NCT07158372Recruiting
Using AI to identify key anatomy in gallbladder surgery videos
This trial uses artificial intelligence to analyze surgery videos and help surgeons identify important structures during gallbladder removal. It may lead to safer procedures.
Zhengzhou, HenanAges 18 years+ - NCT07160907Recruiting
Elderly simulation training for care workers
This study tests if experiencing what it is like to be elderly through a simulation activity can help care workers better understand aging, improve their attitudes, empathy, and communication skills, and increase satisfaction with learning.
Hualien CityAges 20–70 - NCT07188805RecruitingPhase 3
Finerenone for children with heart failure
This study tests a new medicine called finerenone (a pill) to see if it helps children with heart failure who have a weak pumping heart. It compares finerenone to a placebo (a pill with no medicine) while both groups continue their usual heart treatments.
Aurora, ColoradoAges 6 months–17 years - NCT07192952RecruitingPhase 3
Long-term safety of finerenone in children and young adults with heart failure
This study tests the long-term safety of the drug finerenone when taken alongside standard heart failure treatments in children and young adults with weakened heart pumping function (left ventricular systolic dysfunction). It includes both children already in a related study and new infants under 6 months old.
Aurora, ColoradoAges Up to 18 years - NCT07197346Recruiting
Brain stimulation and practice study for healthy young adults
This study tests if a type of brain stimulation called repetitive transcranial magnetic stimulation (rTMS) can improve how well you learn a hand movement task. You will practice a motor task while receiving brief magnetic pulses to your scalp.
TaipeiAges 18–35 - NCT07217795Recruiting
Recovery group for LGBTQ+ mental health and substance use
This trial is testing a new type of talk therapy program designed to help sexual minority women and transgender/gender diverse people recover from mental health and substance use challenges. It focuses on learning coping skills, building self-confidence, solving problems, and finding community support.
Providence, Rhode IslandAges 18 years+ - NCT07219615RecruitingPhase 2
Study of Ritlecitinib for Chronic Hives Not Helped by Antihistamines
This study is testing an experimental daily pill called ritlecitinib for adults whose chronic hives don’t go away with standard antihistamines. It may be a new option if your hives are active and you are not on omalizumab or are willing to stop it for several months.
Phoenix, ArizonaAges 18 years+ - NCT07223723RecruitingPhase 4
Long-term safety of tofersen for SOD1 ALS in China
This study tests the long-term safety of an investigational drug called tofersen (Qalsody) for people in China who have a specific type of ALS caused by a change in the SOD1 gene. If you qualify, you will receive the drug and be monitored for side effects over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07224516Recruiting
Testing medication for opioid use disorder in justice settings
This trial studies how to best increase the use of medication for opioid use disorder (MOUD) in jails or prisons. Sites that join will test ways to start or expand access to these life-saving treatments.
Madison, WisconsinAges 18 years+ - NCT07225517RecruitingPhase 1
Safety study of BIIB145 in healthy adults
This study tests a new drug called BIIB145 in healthy volunteers to see if it's safe and how the body handles it. It helps researchers learn about the drug before testing it in people with specific conditions.
Austin, TexasAges 18–55 - NCT07227233RecruitingPhase 2
AI-guided retrial of CDK4/6 inhibitors for advanced breast cancer
This trial tests whether an artificial intelligence (AI) tool can help doctors decide if it is safe and effective to give you a second course of a CDK4/6 inhibitor drug (like palbociclib, ribociclib, or abemaciclib) plus hormone therapy for advanced (unresectable or metastatic) HR+/HER2- breast cancer. The goal is to only treat people whose cancer is likely to respond based on a special AI analysis of their tumor tissue.
La Jolla, CaliforniaAges 18 years+ - NCT07231627Recruiting
Using AI to improve prostate cancer detection from MRI
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
Little Rock, ArkansasAges 40 years+ - NCT07231991RecruitingPhase 1
How the body processes Vepdegestrant in liver impairment
This study tests how the drug Vepdegestrant is processed by people with different levels of liver function. It aims to understand if liver problems change how the drug works, which can help doctors give the right dose.
Miami, FloridaAges 18–70
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 631 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.